Heterogeneity of surface CD19 and CD22 expression in B lymphoblastic leukemia
- PMID: 30058145
- DOI: 10.1002/ajh.25235
Heterogeneity of surface CD19 and CD22 expression in B lymphoblastic leukemia
Similar articles
-
B-acute leukemic lymphoblasts versus hematogones: the wolf in sheep's clothing/.Leuk Lymphoma. 2009 Apr;50(4):523-4. doi: 10.1080/10428190902725839. Leuk Lymphoma. 2009. PMID: 19373647 No abstract available.
-
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.Nat Med. 2018 Jan;24(1):20-28. doi: 10.1038/nm.4441. Epub 2017 Nov 20. Nat Med. 2018. PMID: 29155426 Free PMC article. Clinical Trial.
-
Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.Leuk Lymphoma. 2011 Jun;52(6):1098-107. doi: 10.3109/10428194.2011.559668. Epub 2011 Feb 24. Leuk Lymphoma. 2011. PMID: 21348573
-
T-cell adoptive immunotherapy for acute lymphoblastic leukemia.Hematology Am Soc Hematol Educ Program. 2013;2013:348-53. doi: 10.1182/asheducation-2013.1.348. Hematology Am Soc Hematol Educ Program. 2013. PMID: 24319203 Free PMC article. Review.
-
CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease.Curr Hematol Malig Rep. 2018 Oct;13(5):396-406. doi: 10.1007/s11899-018-0470-x. Curr Hematol Malig Rep. 2018. PMID: 30120708 Review.
Cited by
-
Tuning the Antigen Density Requirement for CAR T-cell Activity.Cancer Discov. 2020 May;10(5):702-723. doi: 10.1158/2159-8290.CD-19-0945. Epub 2020 Mar 19. Cancer Discov. 2020. PMID: 32193224 Free PMC article.
-
Antigen Loss after Targeted Immunotherapy in Hematological Malignancies.Clin Lab Med. 2021 Sep;41(3):341-357. doi: 10.1016/j.cll.2021.04.005. Epub 2021 Jul 2. Clin Lab Med. 2021. PMID: 34304769 Free PMC article. Review.
-
A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study).Blood. 2021 Mar 25;137(12):1582-1590. doi: 10.1182/blood.2020007848. Blood. 2021. PMID: 33067614 Free PMC article. Clinical Trial.
-
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial.J Clin Oncol. 2023 Mar 20;41(9):1670-1683. doi: 10.1200/JCO.22.01214. Epub 2022 Nov 8. J Clin Oncol. 2023. PMID: 36346962 Free PMC article. Clinical Trial.
-
Mixed-Phenotype Acute Leukemia: Clinical Diagnosis and Therapeutic Strategies.Biomedicines. 2022 Aug 15;10(8):1974. doi: 10.3390/biomedicines10081974. Biomedicines. 2022. PMID: 36009521 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
